Groth, Marie
Katsarava, Zaza
Ehrlich, Marc
Funding for this research was provided by:
Novartis Pharma GmbH, Nuremberg, Germany
Article History
Received: 28 June 2021
Accepted: 7 March 2022
First Online: 17 March 2022
Competing interests
: ZK received research funding from Novartis. He received consultation fees from Allergan, Daiichi, Lilly, Lundbeck, Merck, Novartis, TEVA. None of them were related to this work. MG and ME are Novartis employees.